Aquestive Therapeutics Inc

NASDAQ:AQST 4:00:00 PM EDT

4.03

+0.02 (+0.50%)

7:53:17 PM EDT: $4.01 -0.02 (-0.50%)

Market Cap (Intraday)	400.30M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$11.32 Million
Adjusted EPS	-$0.17

See more estimates

10-Day MA	$3.80
50-Day MA	$3.11
200-Day MA	$3.57

See more pivots

Aquestive Therapeutics Inc Stock, NASDAQ:AQST

30 Technology Drive, Warren, New Jersey 07059

United States of America

Phone: +1.908.941.1900

Number of Employees: 142

http://www.aquestive.com

Description

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patientsÃ¢â?¬â?¢ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.